FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029209582> ?p ?o ?g. }

• W2029209582 endingPage "736" @default.
• W2029209582 startingPage "726" @default.
• W2029209582 abstract "Selenium, in the form of selenocysteine, is a critical component of some major redox-regulating enzymes, including thioredoxin reductase (TrxR) and glutathione peroxidase (Gpx). TrxR has emerged as an anticancer target for drug development due to its elevated expression level in many aggressive human tumors. Acylfulvenes (AFs) are semisynthetic derivatives of the natural product illudin S and display improved cytotoxic selectivity profiles. AF and illudin S alkylate cellular macromolecules. Compared to AFs, illudin S more readily reacts with thiol-containing small molecules such as cysteine, glutathione, and cysteine-containing peptides. However, a previous study indicates that the reactivity of AFs and illudin S with glutathione reductase, a thiol-containing enzyme, is inversely correlated with the reactivity toward small molecule thiols. In this study, we investigate mechanistic aspects underlying the enzymatic and cellular effects of the AFs and illudin S on thioredoxin reductase. Both AF and HMAF were found to inhibit mammalian TrxR in the low- to submicromolar range, but illudin S was significantly less potent. TrxR inhibition by AFs was shown to be irreversible, concentration- and time-dependent, and mediated by alkylation of C-terminus active site Sec/Cys residues. In contrast, neither AFs nor illudin S inhibits Gpx, demonstrating that enzyme structure-specific small molecule interactions have a significant influence over the inherent reactivity of the Sec residue. In human cancer cells, TrxR activity can be inhibited by low micromolar concentrations of all three drugs. Finally, it was demonstrated that preconditioning cells by the addition of selenite to the cell culture media results in an enhancement in cell sensitivity toward AFs. These data suggest potential strategies for increasing drug activity by combination treatments that promote selenium enzyme activity." @default.
• W2029209582 created "2016-06-24" @default.
• W2029209582 creator A5014708973 @default.
• W2029209582 creator A5033601970 @default.
• W2029209582 creator A5064386265 @default.
• W2029209582 date "2011-04-12" @default.
• W2029209582 modified "2023-09-23" @default.
• W2029209582 title "Susceptibility of the Antioxidant Selenoenyzmes Thioredoxin Reductase and Glutathione Peroxidase to Alkylation-Mediated Inhibition by Anticancer Acylfulvenes" @default.
• W2029209582 cites W102115943 @default.
• W2029209582 cites W1546592314 @default.
• W2029209582 cites W1583295309 @default.
• W2029209582 cites W1966593481 @default.
• W2029209582 cites W1967747037 @default.
• W2029209582 cites W1970567191 @default.
• W2029209582 cites W1975113323 @default.
• W2029209582 cites W1976161942 @default.
• W2029209582 cites W1977651412 @default.
• W2029209582 cites W1978870435 @default.
• W2029209582 cites W1987338970 @default.
• W2029209582 cites W1990414820 @default.
• W2029209582 cites W1991303607 @default.
• W2029209582 cites W1993350533 @default.
• W2029209582 cites W1993866135 @default.
• W2029209582 cites W1996700219 @default.
• W2029209582 cites W1996778532 @default.
• W2029209582 cites W2001550232 @default.
• W2029209582 cites W2008991087 @default.
• W2029209582 cites W2009606158 @default.
• W2029209582 cites W2015837249 @default.
• W2029209582 cites W2017192757 @default.
• W2029209582 cites W2018729412 @default.
• W2029209582 cites W2020735633 @default.
• W2029209582 cites W2020821477 @default.
• W2029209582 cites W2021895740 @default.
• W2029209582 cites W2025914723 @default.
• W2029209582 cites W2027724252 @default.
• W2029209582 cites W2028556682 @default.
• W2029209582 cites W2030393522 @default.
• W2029209582 cites W2034207473 @default.
• W2029209582 cites W2037181602 @default.
• W2029209582 cites W2037571897 @default.
• W2029209582 cites W2039675373 @default.
• W2029209582 cites W2040734559 @default.
• W2029209582 cites W2044950028 @default.
• W2029209582 cites W2047558133 @default.
• W2029209582 cites W2048363132 @default.
• W2029209582 cites W2057388890 @default.
• W2029209582 cites W2066205402 @default.
• W2029209582 cites W2067668889 @default.
• W2029209582 cites W2068346906 @default.
• W2029209582 cites W2074256640 @default.
• W2029209582 cites W2079912175 @default.
• W2029209582 cites W2080388275 @default.
• W2029209582 cites W2081376706 @default.
• W2029209582 cites W2082202554 @default.
• W2029209582 cites W2082359412 @default.
• W2029209582 cites W2082813030 @default.
• W2029209582 cites W2086793077 @default.
• W2029209582 cites W2089361349 @default.
• W2029209582 cites W2092317255 @default.
• W2029209582 cites W2102549779 @default.
• W2029209582 cites W2114098967 @default.
• W2029209582 cites W2119009797 @default.
• W2029209582 cites W2121926391 @default.
• W2029209582 cites W2123752358 @default.
• W2029209582 cites W2130440774 @default.
• W2029209582 cites W2132527062 @default.
• W2029209582 cites W2133679449 @default.
• W2029209582 cites W2140455544 @default.
• W2029209582 cites W2145402376 @default.
• W2029209582 cites W2151522311 @default.
• W2029209582 cites W2159797128 @default.
• W2029209582 cites W2163509831 @default.
• W2029209582 cites W2163839210 @default.
• W2029209582 cites W2328449591 @default.
• W2029209582 cites W2950893218 @default.
• W2029209582 cites W4245543343 @default.
• W2029209582 doi "https://doi.org/10.1021/tx2000152" @default.
• W2029209582 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3210965" @default.
• W2029209582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21443269" @default.
• W2029209582 hasPublicationYear "2011" @default.
• W2029209582 type Work @default.
• W2029209582 sameAs 2029209582 @default.
• W2029209582 citedByCount "26" @default.
• W2029209582 countsByYear W20292095822012 @default.
• W2029209582 countsByYear W20292095822013 @default.
• W2029209582 countsByYear W20292095822014 @default.
• W2029209582 countsByYear W20292095822015 @default.
• W2029209582 countsByYear W20292095822016 @default.
• W2029209582 countsByYear W20292095822017 @default.
• W2029209582 countsByYear W20292095822018 @default.
• W2029209582 countsByYear W20292095822019 @default.
• W2029209582 countsByYear W20292095822020 @default.
• W2029209582 countsByYear W20292095822021 @default.
• W2029209582 countsByYear W20292095822022 @default.
• W2029209582 countsByYear W20292095822023 @default.
• W2029209582 crossrefType "journal-article" @default.
• W2029209582 hasAuthorship W2029209582A5014708973 @default.

• next